Showing results (181-190 of 353) with videos related to
Sort By:
Pageof 36
Kidney International|January 28, 2005
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventionsEugenia Nikolsky, Roxana Mehran, Zoran Lasic, et al.European Heart Journal. Acute Cardiovascular Care|February 20, 2021
MEESSI-AHF risk score performance to predict multiple post-index event and post-discharge short-term outcomesXavier Rossello, Héctor Bueno, Víctor Gil, et al.Clinical and Translational Science|July 19, 2023
Totality of evidence of the effectiveness of repurposed therapies for COVID-19: Can we use real-world studies alongside randomized controlled trials?Jaap Mandema, Hugh Montgomery, Louis Dron, et al.Trials|November 26, 2013
Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipidsDaniel J Blackburn, Kailash Krishnan, Lydia Fox, et al.Journal of the American College of Cardiology|September 3, 2021
Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled HypertensionMichael Böhm, Konstantinos Tsioufis, David E Kandzari, et al.Geroscience|May 27, 2026
Telomere length dynamics do not predict subclinical atherosclerosis progression over a six-year periodVicente Andrés, Juan M Fernández-Alvira, Beatriz Dorado, et al.JMIR Human Factors|June 15, 2019
Development of a Clinical Interface for a Novel Newborn Resuscitation Device: Human Factors Approach to Understanding Cognitive User RequirementsLaura Pickup, Alexandra Lang, Lara Shipley, et al.Ophthalmology|December 2, 2009
Verteporfin photodynamic therapy cohort study: report 3: cost effectiveness and lessons for future evaluationsRichard Grieve, Carla Guerriero, Jemma Walker, et al.European Heart Journal|January 5, 2019
Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trialMichael Böhm, Felix Mahfoud, Raymond R Townsend, et al.Cardiovascular Diabetology|November 30, 2018
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)Mikhail Kosiborod, Marilia B Gomes, Antonio Nicolucci, et al.Pageof 36